Could a dissolving heart implant end migraines for good?
NCT ID NCT06203873
First seen Dec 10, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tests if a new biodegradable heart implant can reduce migraine days better than a standard metal implant in people with a common heart hole called PFO. About 400 adults aged 18-65 with frequent migraines and PFO will receive one of the two implants. The goal is to see which device provides more migraine relief over 12 months, with the biodegradable option potentially avoiding long-term complications linked to metal implants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100037, China
-
Fuwai Hospital
RECRUITINGBeijing, Beijing Municipality, 100037, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.